Use of human atherosclerotic cells for optimization of antiatherosclerotic therapy.
Orekhov
A N
AN
Institute of Experimental Cardiology, USSR Cardiology Research Center, Moscow, Russia.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001011:Aorta / Q000378:metabolism / Q000473:pathology; D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy / Q000473:pathology*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002478:Cells, Cultured; D002784:Cholesterol / Q000378:metabolism; D004341:Drug Evaluation; D006801:Humans; D009566:Nitrates / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D009566:Nitrates; D002784:Cholesterol